Cargando…
EGFR敏感突变NSCLC患者的最佳治疗模式探讨
Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been widely used in non-small cell lung cancer (NSCLC) patients, it is still controversial about how to combine EGFR-TKI with chemotherapy and other targeted drugs. We have made a summary on the current therapeutic...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999843/ https://www.ncbi.nlm.nih.gov/pubmed/25676406 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.11 |
| _version_ | 1783331528615395328 |
|---|---|
| collection | PubMed |
| description | Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been widely used in non-small cell lung cancer (NSCLC) patients, it is still controversial about how to combine EGFR-TKI with chemotherapy and other targeted drugs. We have made a summary on the current therapeutic models of EGFR-TKI combined with chemotherapy/bevacizumab in this review and aimed to find the optimal therapeutic strategy for NSCLC patients with EGFR mutation. |
| format | Online Article Text |
| id | pubmed-5999843 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | 中国肺癌杂志编辑部 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59998432018-07-06 EGFR敏感突变NSCLC患者的最佳治疗模式探讨 Zhongguo Fei Ai Za Zhi 综述 Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been widely used in non-small cell lung cancer (NSCLC) patients, it is still controversial about how to combine EGFR-TKI with chemotherapy and other targeted drugs. We have made a summary on the current therapeutic models of EGFR-TKI combined with chemotherapy/bevacizumab in this review and aimed to find the optimal therapeutic strategy for NSCLC patients with EGFR mutation. 中国肺癌杂志编辑部 2015-02-20 /pmc/articles/PMC5999843/ /pubmed/25676406 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.11 Text en 版权所有©《中国肺癌杂志》编辑部2015 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
| spellingShingle | 综述 EGFR敏感突变NSCLC患者的最佳治疗模式探讨 |
| title | EGFR敏感突变NSCLC患者的最佳治疗模式探讨 |
| title_full | EGFR敏感突变NSCLC患者的最佳治疗模式探讨 |
| title_fullStr | EGFR敏感突变NSCLC患者的最佳治疗模式探讨 |
| title_full_unstemmed | EGFR敏感突变NSCLC患者的最佳治疗模式探讨 |
| title_short | EGFR敏感突变NSCLC患者的最佳治疗模式探讨 |
| title_sort | egfr敏感突变nsclc患者的最佳治疗模式探讨 |
| topic | 综述 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999843/ https://www.ncbi.nlm.nih.gov/pubmed/25676406 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.11 |
| work_keys_str_mv | AT egfrmǐngǎntūbiànnsclchuànzhědezuìjiāzhìliáomóshìtàntǎo AT egfrmǐngǎntūbiànnsclchuànzhědezuìjiāzhìliáomóshìtàntǎo |